Predictors and Moderators of Remission with Aripiprazole Augmentation in Treatment-Resistant Late-Life Depression

IMPORTANCE: Safe, efficacious second-line pharmacological treatment options exist for the large portion of older adults with major depressive disorder that does not respond to first-line pharmacotherapy. However, limited evidence exists to aid clinical decision-making regarding which patients will b...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Psychiatry
Autors principals: Kaneriya, Shriya H., Robbins-Welty, Gregg A., Smagula, Stephen F., Karp, Jordan F., Butters, Meryl A., Lenze, Eric J., Mulsant, Benoit H., Blumberger, Daniel, Anderson, Stewart J, Dew, Mary Amanda, Lotrich, Francis, Aizenstein, Howard J., Diniz, Breno S., Reynolds, Charles F.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4823175/
https://ncbi.nlm.nih.gov/pubmed/26963689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2015.3447
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars